TEST BANK FOR CLAYTON’S BASIC PHARMACOLOGY FOR NURSES 18TH EDITION BY WILLIHNGANZ.pdf

TEST BANK FOR CLAYTON’S BASIC PHARMACOLOGY FO
m m m m m m



R NURSES 19th EDITION BY MICHELLE WILLIHNGANZ CH
m m m m m m m



APTER 1-48 m




Chapter m01:mDrug mDefinitions,mStandards,mandmInformationmSources mWillihnganz: mClayton’s mB
asic mPharmacology mfor mNurses,m19thmEdition



MULTIPLEmCHOICE

1. Whichmnamemidentifiesmamdrugmlisted mbymthemUSmFood mand
DrugmAdministrationm(FDA)?
a. Brand
b. Nonproprietary
c. Official
d. Trademark
ANS:m C
Themofficialmnamemismthe
namemundermwhichmamdrugmismlisted
mbymthemFDA.mThembrand mname,mormtrademark,mismthemnamem
givenmtomamdrugmbymitsmmanufacturer.mThemnonproprietary,mo
rmgeneric,mnamem ism provided m bymthem United m Statesm Adopt
ed mNamesmCouncil.
DIF:mCognitivemLevel:mKnowledge REF:mp.m9
OBJ:m1NAT:mNCLEXmClientmNeedsmCategory:mSafe,mEffectivemCaremEnvironme
ntmTOP:mNursingmProcessmStep:mAssessment CON:
PatientmEducation

2. Whichmsourcemcontainsminformationmspecificmtomnutritionalmsupplements?
a. USPmDictionarymofmUSANm&mInternationalmDrugmNames
b. NaturalmMedicinesmComprehensivemDatabase
c. UnitedmStatesmPharmacopoeia/NationalmFormularym(USPmNF)
d. DrugmInteractionmFacts
ANS:mC
UnitedmStatesmPharmacopoeia/NationalmFormularymcontainsminformationmspecificmtom nutritio
nalmsupplements.mUSPmDictionarymofmUSANm&mInternationalmDrugmNamesmismamcompilationmo
f mdrugmnames,mpronunciationmguide,mand mpossiblemfuturemFDA mapproved mdrugs;mit mdoesmnot min
cludemnutritionalmsupplements.mNaturalmMedicinesmComprehensivemDatabasemcontainsmeviden
ce-
based minformationmonmherbalmmedicinesmand mherbalmcombinationmproducts;mit mdoesmnot minclud
eminformationmspecificmtomnutritionalmsupplements.mDrugmInteractionmFactsmcontainsmcompreh
ensiveminformationmonmdrugminteractionmfacts;mit mdoesmnot mincludemnutritionalmsupplements.

DIF:mCognitivemLevel:mKnowledge REF:mp.m4
OBJ:m3 mNAT:mNCLEXmClie
ntmNeedsmCategory:mPhysiologicalmIntegrity
TOP:mNursingmProcessmStep:mAssessment CON:mNutrition m|mPatientmEducation

,Test mBank mForm Clayton’smBasicmPharmacologymformNursesm19thmEditi 2
on 3. Whichmdrugmreferencemcontainsmdrugmmonographsmthat mdescribemallmdrugsminmamtherapeuticmclass?
a. DrugmFactsmandmComparisons
b. DrugmInteractionmFacts
c. HandbookmonmInjectablemDrugs
d. Martindale—ThemCompletemDrugmReference
ANS:mA
DrugmFactsmandmComparisonsmcontainsmdrugmmonographsmthat mdescribemallmdrugsm in
mamtherapeuticmclass. mMonographs mare mformatted masmtablesmtomallow mcomparisonmof msi

milarmproducts,mbrand mnames,mmanufacturers,mcost mindices,mand mavailable mdosagemfor
msmOnlinemversionmismavailable.

DIF:mCognitivemLevel:mKnowledge REF:mp.m4 mTablem1.2
OBJ:m m 3 NAT:mNCLEXmClientmNeedsmCategory:mPhysiologicalmIntegrity
TOP:mNursingmProcessmStep:mAssessment CON:mSafety m|mPatientmEducation m|mClinicalmJudgment

4. Whichmdrugmreferencemcontainsmmonographsmabout mvirtuallymeverymsingle-
entitymdrugmavailableminmthemUnited mStatesmand mdescribesmtherapeuticmusesmof mdrugs,mincludi
ngmapproved mand munapproved muses?
a. Martindale:mThemCompletemDrugmReference
b. AHFSmDrugmInformation
c. DrugmReference
d. DrugmFactsmand mComparisons
ANS:mB
AHFSmDrugmInformationmcontainsmmonographsmabout mvirtuallymevery msingle-
entitymdrugmavailableminmthemUnited mStatesmand mdescribesmtherapeuticmusesmof mdrugs,mincluding
mapproved mand munapproved muses.




DIF:mCognitivemLevel:mKnowledge REF:mp.m4 mTablem1.2
OBJ:m m 3 NAT:mNCLEXmClientmNeedsmCategory:mPhysiologicalmIntegrity
TOP:mNursingmProcessmStep:mPlanning CON:mSafety m|mPatientmEducation m|mClinicalmJudgment

5. Whichm onlinem drugm referencem makesm availablem tom healthcarem providersm and m them public
mamstandard,mcomprehensive,mup-to-
datemlookmupmand mdownloadablemresourcemabout mmedicines?
a. AmericanmDrugmIndex
b. AmericanmHospitalmFormulary
c. DailyMed
d. DrugmReference
ANS:mC
DailyMed mmakesmavailablemtomhealthcaremprovidersmand mthempublicmamstandard,mcomprehensiv
e,mup-to-
datemlookmupmand mdownloadablemresourcemabout mmedicines.mThemAmerican mDrugmIndexmismnot
mappropriatemformpatient muse.mThemAmericanmHospitalmFormularymis mnot mappropriatemformpatie

nt muse.mThemdrugmreferencemismnot mappropriatemformpatient muse.

DIF:mCognitivemLevel:mKnowledge REF:mp.m3 m|mp.m4
OBJ:m3 mNAT:mNCLEXmClie
ntmNeedsmCategory:mPhysiologicalmIntegrity
TOP:mNursingmProcessmStep:mImplementation
CON:mSafety m|mPatientmEducation m|mClinicalmJudgment

6. WhichmlegislationmauthorizesmthemFDA mtomdeterminemthemsafetymof mamdrugmbeforemitsmmarketing?
a. FederalmFood,mDrug,mand mCosmeticmAct m(1938)

,Test mBank mForm Clayton’smBasicmPharmacologymformNursesm19thmEditi 3
on b. DurhammHumphreymAmendment m(1952)
c. Controlled mSubstancesmAct m(1970)
d. KefauvermHarrismDrugmAmendment m(1962)
ANS:mA
ThemFederalmFood,mDrug,mand mCosmeticmAct mof m1938mauthorized mthemFDA mtomdeterminemthems
afetymof mallmdrugsmbeforemmarketing.mLatermamendmentsmand mactsmhelped mtightenmFDA mcontro
lmand mensuremdrugmsafety.mThemDurhammHumphreymAmendment mdefinesmthemkindsmof mdrugsmt
hat mcannot mbemused msafelymwithout mmedicalmsupervisionmand mrestrictsmtheirmsalemtomprescriptio
nmbymamlicensed mpractitioner.mThemControlled mSubstancesmAct maddressesmonlymcontrolled msubs
tancesmand mtheirmcategorization.mThemKefauvermHarrismDrugmAmendment mensuresmdrugmeffica
cymand mgreatermdrugmsafety.mDrugmmanufacturersmaremrequired mtomprovemtomthemFDA mthemeffect
ivenessmof mtheirmproductsmbeforemmarketingmthem.

DIF:mCognitivemLevel:mKnowledge REF:m p.m5 mTableml.3
OBJ:m5
NAT:mNCLEXmClientmNeedsmCategory:mPhysiologicalmIntegrit
y mTOP:mNursingmProcessmStep:mAssessment
CON:mSafety m|mPatientmEducation m|mEvidence m|mHealth mCaremLaw

7. Whichmclassificationmdoesmmeperidinem(Demerol)mfallmunder?ma.
I
b. II
c. III
d. IV
ANS:mB
Meperidinem(Demerol)mismamSchedulemII mdrug;mit mhasmamhighmpotentialmformabusemand mmaymlead
mtomseverempsychologicalmand mphysicalmdependence.mSchedulemI mdrugsmhavemhighmpotentialmfo

rmabusemand mnomrecognized mmedicalmuse.mSchedulemIII mdrugsmhavemsomempotentialmformabuse.m
Usemmaymlead mtomlowmtommoderatemphysicalmdependencemormhighmpsychologicalmdependence.
SchedulemIVmdrugsmhavemlow mpotentialmformabuse.mUsemmaymlead mtomlimited mphysicalmormpsych
ologicalmdependence.

DIF:mCognitivemLevel:mKnowledge REF:mp.m10
OBJ:m2 mNAT:mNCLEXmClie
ntmNeedsmCategory:mSafe,mEffective mCaremEnvironment
TOP:mNursingmProcessmStep:mAssessment CON:mPatientmEducation m|mAddiction m|mPain

8. Whichmactionmwould mthemFDA mtakemtomexpeditemdrugmdevelopment mand mapprovalmformanmoutbre
akmof msmallpox?
a. List msmallpoxmasmamhealthmorphanmdisease.
b. Omit mthempreclinicalmresearchmphase.
c. Extend mthemclinicalmresearchmphase.
d. Fast mtrackmtheminvestigationalmdrug.
ANS:mD
OncemthemInvestigationalmNew mDrugmApplicationmhasmbeenmapproved,mthemdrugmcanmreceivemh
ighest mprioritymwithinmthemagency,mwhichmismcalled mfast mtracking.mAmsmallpoxmoutbreakmwould
mbecomemamprioritymconcernminmthemworld.mOrphanmdiseasesmaremnot mresearched minmamprioritym

manner.mPreclinicalmresearchmismnot momitted.mExtendingmanymphasemof mthemresearchmwould mme
anmamlongermtimemtomdevelopmamvaccine.mThemFDA mmust mensuremthat mallmphases mof mthempreclini
calmand mclinicalmresearchmphasemhavembeenmcompleted minmamsafemmanner.

DIF:mCognitivemLevel:mKnowledge REF:mp.m7 OBJ:m5

, Test mBank mForm Clayton’smBasicmPharmacologymformNursesm19thmEditi 4
on NAT:mNCLEXmClientmNeedsmCategory:mSafe,mEffectivemCaremEnvironmen
tmTOP:mNursingmProcessmStep:mAssessment
CON:mHealth mCaremLawm|mHealth mCaremPolicy m|mInfection m|mCaremCoordination

9. Whichmstatement mismtruemabout mover-the-counterm(OTC)mdrugs?
a. Theymaremnot mlisted minmthemUSPmNF.
b. A mprescriptionmfrommamhealthcaremprovidermismneeded.
c. Theymaremsold mwithout mamprescription.
d. Theymaremknownmonlymbymtheirmbrand mnames.
ANS:mC
OTCmmedicationsmdomnot mrequiremamprescription.mAmvarietymof mnames,mbothmgenericmand mtrade
,mcanmbemused mformindividualmdrugsmsold mOTC.mOTCmdrugsmaremlisted minmthemUSPmNF.mPrescri
ptionmdrugsmrequiremanmordermbymamhealthmprofessionalmwhomismlicensed mtomprescribe, msuchmas m
amphysician,mnursempractitioner,mphysicianmassistant,mormdentist.

DIF:mCognitivemLevel:mComprehension REF:mp.m2
OBJ:m2 mNAT:mNCLEXmClie
ntmNeedsmCategory:mPhysiologicalmIntegrity
TOP:mNursingmProcessmStep:mPlanning CON:mPatientmEducation

10. Whichmismthemmost mauthoritativemreferencemformmedicationsmthat mareminjected?
a. Martindale:mThemComplete
b. HandbookmonmInjectablemDrugs
c. DailyMed
d. HandbookmofmNonprescriptionmDrugs
ANS:mB
ThemHandbookmonmInjectablemDrugsm ismthemmost mcomprehensivemreferencemavailablemonmthem
topicmof mcompatibilitymof minjectable mdrugs.mIt mismamcollectionmof mmonographsmformmoremthanm3
00minjectablemdrugsmthat maremlisted malphabeticallymbymgenericmname.

DIF:mCognitivemLevel:mKnowledge REF:mp.m4
OBJ:m3 mNAT:mNCLEXmClie
ntmNeedsmCategory:mPhysiologicalmIntegrity
TOP:mNursingmProcessmStep:mAssessment CON:mClinicalmJudgmentm|mSafety

11. Whichmstatement mismtruemabout mLomotil?
a. Abusempotentialmformthismdrugmismlow.
b. Psychologicalmdependencymismlikely.
c. Theremismamhighmpotentialmformabuse.
d. Thismdrugmismnot mamcontrolled msubstance.
ANS:mA
Lomotil,mamSchedulemVmdrug,mhasmanmabusempotentialmof mlimited mphysicalmormpsychologicalmde
pendencemliabilitymcompared mwithmdrugsminmSchedulemIV.mBecausemabusempotentialmismlowmwi
thmamSchedulemVmdrug,mamprescriptionmmaymnot mbemrequired.mPsychologicalmdependencymismnot
mlikelymwithmamSchedulemV mdrug.mSchedulemV mdrugsmaremclassified masmcontrolled msubstances.




DIF:mCognitivemLevel:mKnowledge REF:mp.m5 mBox m1.1
OBJ:m2 mNAT:mNCLEXmClie
ntmNeedsmCategory:mPhysiologicalmIntegrity
TOP:mNursingmProcessmStep:mAssessment CON:mClinicalmJudgmentm|mSafety m|mPatientmEducation
12. Whichmmedicationmordered mformampatient mwithmamsubstancemabusemhistorymhasmthemgreat
est mriskmformabuse?
a. Lomotil